Business

Italy’s UniCredit says it is withdrawing bid for Banco BPM

 UniCredit on Tuesday said it was withdrawing its 14.6 billion euro ($17 billion) all-share bid for Banco BPM.

Italy’s second-biggest bank said in a statement government-set terms for the bid, which it has been fighting in court scoring a partial victory earlier this month, had derailed the bid.

“The normal offer process has been impacted by the Golden Power provision,” the bank said, referring to special powers Rome has to set conditions, or block, corporate deals on grounds of public order or national security.

UniCredit said a 30-day suspension of the bid which market watchdog Consob decided earlier on Tuesday was not sufficient to get to a point where all uncertainty around the scope of the government’s powers would be cleared.

Source : Reuters

GLOBAL BUSINESS AND FINANCE MAGAZINE

Recent Posts

Greening at the border: Carbon Border Adjustment Mechanism incidence on EU member states and their trading partners

The EU’s Carbon Border Adjustment Mechanism seeks to address carbon leakage and ensure fair competition…

4 days ago

How emerging markets borrow: New evidence on sovereign bond issuance

Emerging market debt has surged since the pandemic, renewing concerns about rollover risk and fiscal…

5 days ago

The content moderator’s dilemma: How removing toxic speech distorts online discourse

Online platforms face a fundamental tension between removing toxic content and preserving the plurality of…

5 days ago

Information equalisation and competition in selection markets: Evidence from auto insurance

Efforts to reduce information asymmetries across firms are increasingly at the centre of Europe’s digital…

5 days ago

Beyond oil: The macroeconomic impact of commodity supply disturbances

As geopolitical tensions from Ukraine to the Middle East disrupt global supply chains, understanding how…

5 days ago

From free rider to innovator: How China became a global pharmaceutical powerhouse

China has become a serious contender at the frontier of pharmaceutical innovation. A key policy…

5 days ago